NCI Events

NCI Transition Career Development Workshop

To facilitate current NCI career development awardees and prospective applicants to become better acquainted with the elements involved in transitioning to research independence.

DCP Early Career Scientist Spotlight Research Seminar Series

The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) has created the DCP Early Career Scientist Spotlight Research Seminar Series to highlight nominated early career scientists who are advancing research within the areas supported by DCP. The overall goal of this ongoing seminar series is to increase visibility and provide recognition to these DCP Early Career Scientists.

CCDI Webinar Series

Throughout the year, CCDI will host open Community Forums, which highlight CCDI progress and what’s on the horizon for the initiative. These forums cover CCDI programs, such as the Rare Pediatric Cancer Initiative and the CCDI Participant Index.

Tumor-Draining Lymph Nodes: Gaps and Opportunities Forum Series

This initiative will convene a monthly virtual forum series bringing together leading experts in lymph node biology, immunology, and cancer—from experimental scientists and clinicians to computational and in silico modelers—in a dynamic, interdisciplinary environment. 

Cancer Target Discovery and Development (CTD²) Network Annual Meeting

During the Cancer Target Discovery and Development (CTD²) Network Virtual Symposium, CTD2 researchers will share functional genomics research that is bridging the gap between large-scale genomic datasets and the underlying etiology of cancer development, progression, and metastasis.

Immune Aging and Cancer Therapy Meeting

Host immunity has been successfully leveraged to improve cancer therapy outcomes but one’s immune function and resilience decrease with advancing age. This virtual workshop will focus on the impact of immune aging on cancer therapy and discuss opportunities and future directions in this area.

DCTD Workshop: Foundation Models for Cancer- Advancing Diagnosis, Prognosis, and Treatment Response

This virtual workshop, "Foundation Models for Cancer," will be held from March 24-26, 2026, between 10:00 AM and 2:00 PM EST. This workshop will explore how foundation models—a powerful class of advanced AI models —can transform cancer research and clinical care. We will focus on their potential to improve diagnosis, prognosis, and treatment response, with a strong emphasis on clinical translation and technology development.

Cancer-Alzheimer's Disease Inverse Correlation (CADIC): From Biological Mechanisms to Therapeutic Potential Workshop

Epidemiological studies consistently report an inverse correlation between cancer and Alzheimer’s disease (AD). Currently, a critical gap exists between the repeatedly observed inverse association of the two diseases in epidemiological studies and a mechanistic understanding of this compelling phenomenon. To address this knowledge gap, this NIA/NCI workshop will convene experts in AD, cancer biology, statistics, epidemiology, and translational/clinical research to discuss this topic and the challenges faced by this nascent field.

I-SCORE: Investigators' and Site Coordinators' Opportunity for Research Excellence Meeting

he NCI Division of Cancer Prevention (DCP) develops, supports, and oversees clinical cancer prevention trials and promotes participation by all populations. The Early Phase Cancer Prevention Clinical Trials Program is designed to evaluate the safety and efficacy of promising new preventive agents, the utility of novel biomarkers, and the value of innovative technologies to identify premalignant lesions. The Cancer Prevention Clinical Trials Network (CP-CTNet) was created to facilitate the efficient implementation of these studies by teams of multidisciplinary investigators supported by NCI DCP. The purpose of the I-SCORE meeting is to stimulate information sharing and collaborations between DCP staff and CP-CTNet members including investigators, program staff and coordinators; and to develop strategies to enhance the cancer prevention research program both scientifically and operationally.

Annual HIV DRP Think Tank Meeting

The HIV Dynamics and Replication Program (HIV DRP), Center for Cancer Research (CCR), National Cancer Institute (NCI), will hold their 29th Annual DRP Think Tank Meeting, on Tuesday, April 14, 2026. This meeting will consist of a series of short (15 minutes or less) presentations by members of the local virology community on topics related to HIV, AIDS, retrovirus biology, and cancer virology.

Translating Emerging Cancer Diagnostics and Technologies toward Clinical Impact Meeting

NCI’s Division of Cancer Treatment and Diagnosis (DCTD) is hosting a two-day virtual workshop focused on accelerating innovative cancer diagnostics and technology platforms from discovery to clinical application. The program brings together senior and early-stage investigators from academia and industry, highlights NCI-supported case studies, and showcases NCI funding and commercialization pathways within the broader NCI innovation ecosystem.

SCLC Consortium Meeting

This hybrid meeting will host national and international experts in the dynamic field of SCLC research. It will cover the most recent developments in SCLC biology, models, tumor heterogeneity and plasticity, immunology and immunotherapy, new therapy targets, and treatment resistance. The sessions will aim to develop collaborative approaches to address key questions in the field and define promising scientific areas.

NCI Program Staff and patient advocates with an interest in SCLC are also invited guests. We hope this venue will enable data sharing with the intent to offer many new collaborative opportunities within the SCLC community.

26th Annual CCR Fellows and Young Investigators Colloquium

In 2026, we are celebrating the 26th Annual CCR Fellows and Young Investigators Colloquium, a two-day event held at the NCI Shady Grove Campus (9609 Medical Center Drive in Rockville, MD).

We are offering keynote addresses from research speakers, a survivorship speaker, the Outstanding Postdoctoral Fellow (OPF) awardee, and CCR leadership. Importantly, we highlight the research by CCR fellows, giving opportunities for oral and poster presentations. For career development, we host a variety of panels and workshops by experts from different fields. The Colloquium will be held on May 14–15, 2026, and is open to all NCI fellows and trainees.

Science-Based Non-Academic Careers

As fellows and staff scientists at the National Cancer Institute, many of you will be exploring and choosing from various science-based career options in the future. The Office of Training and Education (OTE) in the Center for Cancer Training (CCT) is hosting weekly workshops to help participants learn about the various career opportunities that lie outside of independent academic research. Given these may include unfamiliar roles outside of traditional bench science, we have guest speakers from various science-based backgrounds to provide information and insight that will help inform decisions about potential future endeavors. For details about the course schedule, invited speakers, and program contacts, please visit the SNAC website.

Summer Omics Nursing Institute

The Summer Omics Nursing Institute will equip nurses with the knowledge, skills, and abilities to develop robust programs of research in symptom science that incorporate molecular omics. Participants will expand their understanding of molecular omic concepts and methods for application in research, teaching, and clinical practice, and will gain the ability to apply these approaches in biobehavioral research. The program will also examine strategies and emerging trends in omic-based therapies and molecular therapeutics, while building critical skills to evaluate the strengths, limitations, and appropriate applications of omic testing, including potential sources of inaccuracy when used in symptom science.

NCI Data Jamboree

The National Cancer Institute (NCI) invites you to participate in the 2026 NCI Data Jamboree: Enhancing Data Sharing and Utility to Advance Cancer Research on November 16-18 at the NIH Neuroscience Building in Rockville, Maryland. The overarching goal is to promote data sharing and use, facilitate interdisciplinary collaborations, and engage and expand the size and scientific diversity of the cancer research community.